Minimally Invasive Surgical Therapy for BPH
Phase 3
Terminated
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Device: Transurethral Needle Ablation (TUNA) TherapyDevice: Transurethral Microwave Thermotherapy (TUMT)
- Registration Number
- NCT00064649
- Brief Summary
The primary objective of this randomized clinical trial is to determine the efficacy and safety of three treatments for benign prostatic hyperplasia (BPH): transurethral needle ablation (TUNA), transurethral microwave therapy (TUMT), and medical therapy with alfuzosin and finasteride.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Male
- Target Recruitment
- 49
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Transurethral Needle Ablation (TUNA) Therapy Transurethral Needle Ablation (TUNA) 3 Finasteride and Alfuzosin finasteride in a daily dose of 5 mg and alfuzosin in a daily dose of 10 mg 1 Transurethral Microwave Thermotherapy (TUMT) Transurethral Microwave Thermotherapy (TUMT)
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (7)
Northwestern University
🇺🇸Chicago, Illinois, United States
University of Texas Southwestern Medical Center
🇺🇸Dallas, Texas, United States
Baylor College of Medicine
🇺🇸Houston, Texas, United States
Columbia University
🇺🇸New York, New York, United States
Mayo Clinic
🇺🇸Rochester, Minnesota, United States
University of Colorado Health Sciences Center
🇺🇸Denver, Colorado, United States
Medical College of Wisconsin
🇺🇸Milwaukee, Wisconsin, United States